Nanoparticle-Mediated Mitochondrial Damage Induces Apoptosis in Cancer
Related Experiment Video
Updated: Mar 21, 2026

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity
Published on: May 12, 2020
Abhik Mallick1, Piyush More1, Muhammed Muazzam Kamil Syed1
1Department of Chemistry, Indian Institute of Science Education and Research (IISER)-Pune , Pune, 411008, Maharashtra, India.
Abstract:
Detouring of conventional DNA damaging anticancer drugs into mitochondria to damage mitochondrial DNA is evolving as a promising strategy in chemotherapy. Inhibiting single target in mitochondria would eventually lead to the emergence of drug resistance. Moreover, targeting mitochondria selectively in cancer cells, keeping them intact in healthy cells, remains a major challenge. Herein, triphenylphosphine (TPP)-coated positively charged 131.6 nm spherical nanoparticles (NPs) comprised of α-tocopheryl succinate (TOS, inhibitor of complex II in electron transport chain) and obatoclax (Obt, inhibitor of Bcl-2) were engineered. The TOS-TPP-Obt-NPs entered into acidic lysosomes via macropinocytosis, followed by lysosomal escape and finally homed into mitochondria over a period of 24 h. Subsequently, these TOS-TPP-Obt-NPs triggered mitochondrial outer membrane permeabilization (MOMP) by inhibiting antiapoptotic Bcl-2, leading to Cytochrome C release. These TOS-TPP-Obt-NPs mediated mitochondrial damage induced cellular apoptosis through caspase-9 and caspase-3 cleavage to show improved efficacy in HeLa cells. Moreover, TOS-TPP-Obt-NPs induced MOMP in drug-resistant triple negative breast cancer cells (MDA-MB-231), leading to remarkable efficacy, compared to the combination of free drugs in higher drug concentrations. Results presented here clearly stimulate the usage of multiple drugs to perturb simultaneously diverse targets, selectively in mitochondria, as next-generation cancer therapeutics.
Insights
Mitochondria-targeting nanoparticles loaded with two drugs overcome cancer drug resistance. These nanoparticles induce mitochondrial damage and apoptosis, showing promise for next-generation cancer therapeutics.
Area of Science:
- Biochemistry
- Nanotechnology
- Oncology
Background:
- Mitochondrial DNA targeting is a promising chemotherapy strategy.
- Single-target inhibition leads to drug resistance, and selective mitochondrial targeting is challenging.
- Developing multi-drug strategies for simultaneous mitochondrial targeting is crucial.
Purpose of the Study:
- To engineer triphenylphosphine (TPP)-coated nanoparticles (NPs) carrying α-tocopheryl succinate (TOS) and obatoclax (Obt).
- To investigate the selective delivery of TOS-TPP-Obt-NPs to cancer cell mitochondria.
- To evaluate the efficacy of TOS-TPP-Obt-NPs in inducing apoptosis and overcoming drug resistance.
Main Methods:
- Engineered 131.6 nm spherical nanoparticles coated with TPP and loaded with TOS and Obt.
- Investigated nanoparticle uptake via macropinocytosis, lysosomal escape, and mitochondrial homing over 24 hours.
- Assessed mitochondrial outer membrane permeabilization (MOMP), Cytochrome C release, and caspase cleavage in HeLa and MDA-MB-231 cells.
Main Results:
- TOS-TPP-Obt-NPs successfully entered lysosomes, escaped, and localized to mitochondria.
- NPs triggered MOMP by inhibiting Bcl-2, leading to Cytochrome C release and apoptosis via caspase-9 and caspase-3 cleavage.
- Demonstrated improved efficacy in HeLa cells and significant efficacy in drug-resistant MDA-MB-231 cells compared to free drugs.
Conclusions:
- Simultaneous perturbation of diverse mitochondrial targets using multi-drug nanoparticles is a viable strategy.
- TPP-coated TOS-Obt NPs offer a promising approach for next-generation cancer therapeutics.
- This strategy effectively induces apoptosis and overcomes drug resistance in cancer cells.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
13:20Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro
Published on: July 17, 2018
Related Concept Videos
The Intrinsic Apoptotic Pathway
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Apoptosis
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Mitochondrial Membranes
The Extrinsic Apoptotic Pathway